Intervention Review

You have free access to this content

Microwave coagulation for liver metastases

  1. Malgorzata M Bala1,*,
  2. Robert P Riemsma2,
  3. Robert Wolff2,
  4. Jos Kleijnen3

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 13 OCT 2013

Assessed as up-to-date: 21 DEC 2012

DOI: 10.1002/14651858.CD010163.pub2


How to Cite

Bala MM, Riemsma RP, Wolff R, Kleijnen J. Microwave coagulation for liver metastases. Cochrane Database of Systematic Reviews 2013, Issue 10. Art. No.: CD010163. DOI: 10.1002/14651858.CD010163.pub2.

Author Information

  1. 1

    Jagiellonian University Medical College, 2nd Department of Internal Medicine, Krakow, Poland

  2. 2

    Kleijnen Systematic Reviews Ltd, York, UK

  3. 3

    School for Public Health and Primary Care (CAPHRI), Maastricht University, Maastricht, Netherlands

*Malgorzata M Bala, 2nd Department of Internal Medicine, Jagiellonian University Medical College, 8 Skawinska St, Krakow, 31-066, Poland. gosiabala@mp.pl.

Publication History

  1. Publication Status: New
  2. Published Online: 13 OCT 2013

SEARCH

References

References to studies included in this review

  1. References to studies included in this review
  2. Additional references
Shibata 2000 {published data only}

Additional references

  1. References to studies included in this review
  2. Additional references
Bala 2011
  • Bala MM, Riemsma RP, Wolff R, Kleijnen J. Cryotherapy for liver metastases. Cochrane Database of Systematic Reviews 2011, Issue 3. [DOI: 10.1002/14651858.CD009058]
Bala 2013
  • Bala MM, Riemsma RP, Wolff R, Kleijnen J. Transarterial (chemo)embolisation versus other nonsurgical ablation methods for liver metastases. Cochrane Database of Systematic Reviews 2013, Issue 6. [DOI: 10.1002/14651858.CD010588]
Bangalore 2008
  • Bangalore S, Wetterslev J, Pranesh S, Sawhney S, Gluud C, Messerli FH. Peri-operative beta-blockers in patients undergoing non-cardiac surgery: a meta-analysis and trial sequential analysis of 12,306 patients from randomised trials. Lancet 2008;372(9654):1962-76.
Bilchik 2000
  • Bilchik AJ, Wood TF, Allegra D, Tsioulias GJ, Chung M, Rose DM, et al. Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm. Archives of Surgery 2000;135(6):657-64.
Bipat 2007
  • Bipat S, van Leeuwen MS, Ijzermans JNM, Comans EFI, Planting AS, Bossuyt PMM, et al. Evidence-based guideline on management of colorectal liver metastases in the Netherlands. Netherlands Journal of Medicine 2007;65(1):5-14.
Boutros 2010
  • Boutros C, Somasundar P, Garrean S, Saied A, Espat NJ. Microwave coagulation therapy for hepatic tumors: review of the literature and critical analysis. Surgical Oncology 2010;19(1):e22-e32.
Brok 2008
  • Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. Journal of Clinical Epidemiology 2008;61:763-9.
Brok 2009
  • Brok J, Thorlund K, Wetterslev J, Gluud C. Apparently conclusive meta-analyses may be inconclusive-trial sequential analysis adjustment for random error risk in conclusive neonatal meta-analyses. International Journal of Epidemiology 2009;38:287-98.
Cirocchi 2012
  • Cirocchi R, Trastulli S, Boselli C, Montedori A, Cavaliere D, Parisi A, et al. Radiofrequency ablation in the treatment of liver metastases from colorectal cancer. Cochrane Database of Systematic Reviews 2012, Issue 6. [DOI: 10.1002/14651858.CD006317.pub3]
CTU 2011
  • Copenhagen Trial Unit. TSA - Trial Sequential Analysis. http://ctu.dk/tsa/ 2011 (accessed 4 September 2012).
Decadt 2004
DerSimonian 1986
Egger 1997
  • Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical Research Education) 1997;315:629–34.
FDA 2013
  • U.S. Food, Drug Administration. FDA approvals and investigational device exemptions. http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/HowtoMarketYourDevice/InvestigationalDeviceExemptionIDE/default.htm (accessed 29 May 2013).
Geoghegan 1999
Gluud 2008
  • Gluud LL, Thorlund K, Gluud C, Woods L, Harris R, Sterne JA. Correction: reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine 2008;149:219.
Gluud 2013
  • Gluud C, Nikolova D, Klingenberg SL, Alexakis N, Als-Nielsen B, Colli A, et al. Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)). 2013, Issue 8. Art. No.: LIVER.
Greenland 1985
Higgins 2011
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
Hugh 1997
IARC 2008
  • International Agency for Research on Cancer. GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. http://globocan.iarc.fr/ 2008 (accessed 29 May 2013).
ICH-GCP 1997
  • International Conference on Harmonisation Expert Working Group. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice CFR & ICH Guidelines. Vol. 1, PA 19063-2043, USA: Barnett International/PAREXEL, 1997.
Jemal 2010
Kjaergard 2001
Lau 2000
Lau 2003
Llovet 2003
Lopez 2006
Lundh 2012
Mantel 1959
Markovic 1998
  • Markovic S, Gadzijev E, Stabuc B, Croce L, Masutti F, Surlan M. Treatment options in Western hepatocellular carcinoma: a prospective study of 224 patients. Journal of Hepatology 1998;29:650-9.
Marlow 2006
  • Marlow NE, et al. Radiofrequency ablation for the treatment of liver tumours: a systematic review. ASERNIP-S Report No. 56, 2006. http://www.surgeons.org/media/17297/RFAupdate.pdf (accessed 29 May 2013).
McCarter 2000
McLoughlin 2006
  • McLoughlin JM, Jensen EH, Malafa M. Resection of colorectal liver metastases: current perspectives. Cancer Control 2006;13(1):32-41.
Michel 2002
  • Michel S, Sue B, Montpeyroux F, Hachemanne S, Blanc P, Domergue J. Liver resection or transplantation for hepatocellular carcinoma?. Journal of Hepatology 2002;26:1274-80.
Moher 1998
  • Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998;352:609-13.
NCI 2009
  • National Cancer Institute. SEER Cancer statistics review, 1975-2007. http://seer.cancer.gov/csr/1975_2007/ (accessed 29 May 2013).
NICE 2011
  • NICE Guidance. Microwave ablation for the treatment of liver metastases (IPG406). http://publications.nice.org.uk/microwave-ablation-for-the-treatment-of-liver-metastases-ipg406 2011 (accessed 29 May 2013).
Parkin 2002
Parmar 1998
Pathak 2011
Riemsma 2009
  • Riemsma R, Bala M, Wolff R, Kleijnen J. Non-surgical ablation methods for primary malignant liver tumours and liver metastases, 2009. http://www.cvz.nl/binaries/live/cvzinternet/hst_content/nl/documenten/standpunten/2009/sp0905+interventies+levertumoren.pdf (accessed 29 May 2013).
Riemsma 2010
  • Riemsma RP, Bala M, Wolff R, Kleijnen J. Percutaneous ethanol injection for liver metastases. Cochrane Database of Systematic Reviews 2010, Issue 9. [DOI: 10.1002/14651858.CD008717]
Riemsma 2011
  • Riemsma RP, Bala MM, Wolff R, Kleijnen J. Transarterial (chemo)embolisation for liver metastases. Cochrane Database of Systematic Reviews 2011, Issue 12. [DOI: 10.1002/14651858.CD009498]
Royle 2003
  • Royle P, Milne R. Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care 2003;19(4):591-603.
Savovic 2012
  • Savovic J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J, et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Health Technology Assessment 2012;16(35):1-82.
Savovic 2012a
  • Savovic J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J, et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Annals of Internal Medicine 2012;157(6):429-38.
Schulz 1995
  • Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-12.
Schwartz 2004
  • Schwartz JD, Beutler AS. Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials-II: systemic and local non-embolization-based therapies in unresectable and advanced hepatocellular carcinoma. Anti-Cancer Drugs 2004;15:439-52.
Simon 2005
SPIRIT 2013a
  • Chan A-W, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, et al. SPIRIT 2013 Statement: Defining standard protocol items for clinical trials. Annals of Internal Medicine 2013;158:200-7.
SPIRIT 2013b
  • Chan A-W, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin J, et al. SPIRIT 2013 Explanation and elaboration: Guidance for protocols of clinical trials. BMJ (Clinical Research Ed.) 2013;346:e7586.
Sutherland 2006
Thierney 2007
Thorlund 2009
  • Thorlund K, Devereaux PJ, Wetterslev J, Gyuatt G, Ioannidis JPA, Thabane L, et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?. International Journal of Epidemiology 2009;38:276-86.
Thorlund 2010
  • Thorlund K, Anema A, Mills E. Interpreting meta-analysis according to the adequacy of sample size: an example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals. Clinical Epidemiology 2010;2:57-66.
Thorlund 2011
  • Thorlund K, Engstrøm J, Wetterslev J, Brok J, Imberger G, Gluud C. User manual for trial sequential analysis (TSA). http://ctu.dk/tsa/files/tsa_manual.pdf 2011 (accessed 30 May 2013).
Weiss 1986
Wetterslev 2008
  • Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. Journal of Clinical Epidemiology 2008;61(1):64-75.
Wetterslev 2009
  • Wetterslev J, Thorlund K, Brok J, Gluud C. Estimating required information size by quantifying diversity in a random-effects meta-analysis. BMC Medical Research Methodology 2009;9:86.
WHO 2012
  • World Health Organization. International Clinical Trials Registry Platform (ICTRP). http://www.who.int/ictrp/en/ (accessed 29 May 2013).
Wood 1976
  • Wood C, Gillis C, Blumgart L. A retrospective study of patients with liver metastases from colorectal cancer. Clinical Oncology 1976;2:285-8.
Wood 2008
  • Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman DG, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ (Clinical Research Education) 2008;336(7644):601-5.